Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Rigel's Punishment May Prove Short-Sighted
- EP Vantage submits: Rigel Pharmceuticals' RIGL shares have lost almost half their value this week since the release of fresh data from a phase II study of its lead product, R788 in rheumatoid arthritis, which considering the new information was neither overwhelmingly negative, nor entirely new, seems an overly severe...
- External links 2008-10-31
Additional Resources
- Rigel and Seattle Genetics: The Delicate Art of Expectation Management
- Ohad Hammer submits: In my previous article, I discussed the pharmaceutical industry’s race after approved drugs and late stage agents with proof of concept in humans. I mentioned Rigel’s RIGL lead drug, R788, as a likely target for collaboration due to its impressive activity, the huge addressable market and the...
- External links 2009-02-09
- Talisman Offer for Rigel Successful.(Brief Article)
- Talisman Energy Inc., Calgary, AB, announced that approximately 55 million common shares have been tendered in response to its offer to purchase all of the common shares of Rigel Energy Corporation. This represents over 95 per cent of Rigel shares on a fully diluted basis. All...
- Research articles 1999-11-01
- Rigel Corp.: driven by unique management style and an ability to adapt
- The corporate structure at Rigel Corp. is so informal that the presidency rotates every few years. The two men sharing the power at Rigel are the company's founders: John Chisholm and Jim Morrissey. "We change positions every few years, mostly for the purpose of our bank...
- Research articles 1998-01-01
- Rigel Corp. to co-brand Godfather's, Bruegger's
- OMAHA, Neb. -- Rigel Corp., a franchisee of Godfather's Pizza, Bruegger's Bagels and KFC, based here, is building three dual-brand outlets in the Phoenix area, combining the Godfather's and Bruegger's brands on a single site. All three ground-up units are expected to open by year-end, according to Vincent Morrissey, a...
- Research articles 1997-05-26
- Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium
- Compared With Pfizer's Oral Jak-3 inhibitor, Rigel's Novel Oral Agent Will Garner Considerably Less Patient Share and Sales WALTHAM, Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, today released its updated Pharmacor Rheumatoid...
- Research articles 2009-08-06
- Rigel Inc. Completes First Financing; Broad-based Technology Couples Genomics with Rapid Drug Discovery
- SUNNYVALE, Calif.--BW HealthWire--March 6, 1997--Executives at Rigel Inc. today announced the successful closure of the company's first financing round which raised $6 million from private investors including Alta Partners, San Francisco and Lombard Odier, Zurich. Rigel, founded in 1996, utilizes proprietary technology capable of creating intracellular combinatorial...
- Research articles 1997-03-06
- New Analyst Reports for PACCAR INC, LKQ CORP, MICROCHIP TECHNOLOGY INC, and RIGEL PHARMACEUTICALS INC
- MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for PACCAR...
- Research articles 2008-06-03
- Zacks #1 Rank Top Performers: CTI Industries, Crocs, Rigel Pharmaceuticals, Allis-Chalmers Energy and Oregon Steel Mills
- CHICAGO -- Zacks.com announces the latest list of top performing Zacks #1 Rank Strong Buy stocks. The stocks on the prestigious list with the highest returns last week were CTI Industries Corporation (NASDAQ: CTIB), Crocs, Inc. (NASDAQ: CROX), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), Allis-Chalmers Energy Inc. (AMEX: ALY) and Oregon...
- Research articles 2006-10-17
- Rigel Still on Track, And Has Pfizer Found Its Next Blockbuster?
- Ohad Hammer submits: In the pharmaceutical industry, 2008 will probably be marked by the big pharmas’ insatiable appetite for new drugs. Threatened by fierce generic competition, the pharmaceutical giants were not only eager to pay generous acquisition premiums for marketed products, but were also willing to pay a lot of...
- External links 2009-01-08
- Rigel Pharmaceuticals: A Game Changer in the Works?
- Dr. Anthony submits: With the impending announcement of the Phase IIb data for Rigel's RIGL lead compound R-788, I thought I would share my analysis. Rheumatoid Arthritis is a chronic debilitating disease that requires life-long treatment, which makes it a lucrative market but also at the same time very competitive....
- External links 2009-06-28
- Rigel Pharma: The Importance of Knowing Your Stock
- Stone Fox Capital submits: Last Thursday night, Rigel Pharma RIGL released disappointing results on its TASKi3 Phase 2b study on Rheumatoid Arthritis (RA). The results showed that the placebo worked basically as well as the R788 pill. Now here is where you need to understand the stock and what was...
- External links 2009-07-29
- Rigel Corp. sells 20 Godfather's units
- OMAHA, NEB. -- Rigel Corp., a franchisee of Godfather's Pizza, KFC, Krispy Kreme and Bruegger's Bagel Bakery based here, has sold 20 of its Godfather's holdings, including eight here, to KT Restaurants LLC. Terms were not disclosed.
- Research articles 2000-02-21
- NOVARTIS.
- NOVARTIS Pharma AG and Rigel Inc. have signed agreements for five different five-year drug discovery research projects using Rigel's functional genomics technology. Novartis will ... NOVARTIS Pharma AG and Rigel Inc. have signed agreements for five different five-year drug discovery research projects using Rigel's...
- Research articles 1999-06-21
- Incyte Corporation Q2 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you. Operator instructions Our first question is coming from Tom Russo with Robert W. Baird. Please state your question. Tom Russo – Robert W. Baird Good morning and congrats on all the progress in the last three months. Paul Friedman Thank you. Tom Russo – Robert...
- Earnings calls 2009-07-30
- Com-Power Buys Seaward's EMC Line
- The Seaward Group of companies has sold its electromagnetic compatibility product business to Com-Power of California, reports EE Times UK. The electromagnetic compatibility test product range had been developed over a period of 10 years with the aid of a network of United Kingdom universities. The group also includes Seaward...
- Research articles 2003-11-01
- Market Pulse Breaking News Alert for Monday, August 2, 2004: AANI - Amedia Networks Expands Licensing Agreement With Lucent Technologies!
- Market Pulse News Alert for this AM, Stocks to Watch are: Amedia Networks, Inc. (OTC BB: AANI), Procter & Gamble Co. (NYSE: PG), Cox Communications Inc. (NYSE: COX) and Rigel Pharmaceuticals Inc. (NASDAQ: RIGL).
- Research articles 2004-08-02
- Wall Street News Alert Issues Special Alert on ELHI! December 14, 2007
- Wall Street News Alert's "stocks to watch" this morning are: Edgeline Holdings, Inc. (OTCBB: ELHI), Microsoft (NASDAQ: MSFT), AMIS Holdings, Inc. (NASDAQ: AMIS) and Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL).
- Research articles 2007-12-14
- Wheat harvest better than expected -- but not great
- ENID AP -- When the government estimated Oklahoma would produce 94 million bushels of wheat this harvest season, local grain experts felt it might be a little more than that. They were right. According to Troy Rigel, vice president of marketing at W.B. Johnston Grain Co., the...
- Research articles 2001-07-23
- Issues Thursdays Stocks to Watch: ORMP! April 12, 2007.
- M2 PRESSWIRE-12 April 2007-Wall Street Capital Funding LLC: Issues Thursdays Stocks to Watch: ORMP! April 12, 2007C1994-2007 M2 COMMUNICATIONS LTD RDATE:12042007 Weston, FLA. - Wall Street News Alert's "stocks to watch" this morning are: Oramed Pharmaceuticals Incorporated (OTCBB: ORMP), Healthnostics,...
- Research articles 2007-04-12
- << Previous
- page 1 of 1
- Next >>
